347
Views
10
CrossRef citations to date
0
Altmetric
Original Article: Research

Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease

, , , , , , , , , & show all
Pages 186-193 | Received 17 Dec 2013, Accepted 02 Mar 2014, Published online: 29 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Antonin Papin, Steven Le Gouill & David Chiron. (2018) Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment. Leukemia & Lymphoma 59:5, pages 1064-1072.
Read now

Articles from other publishers (9)

Kang Le, Jing Sun, Javid Ghaemmaghami, Mitchell R. Smith, W. K. Eddie Ip, Tycel Phillips & Mamta Gupta. (2023) Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity. Blood Advances 7:15, pages 3952-3967.
Crossref
Kang Le, Jing SunHunain Khawaja, Maho Shibata, Sanjay B. Maggirwar, Mitchell R. Smith & Mamta Gupta. (2021) Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis. Blood Advances 5:14, pages 2863-2878.
Crossref
Antonin Papin, Benoit Tessoulin, Céline Bellanger, Anne Moreau, Yannick Le Bris, Hervé Maisonneuve, Philippe Moreau, Cyrille Touzeau, Martine Amiot, Catherine Pellat-Deceunynck, Steven Le Gouill & David Chiron. (2019) CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages. Leukemia 33:10, pages 2442-2453.
Crossref
Mulder, Wahlin, Österborg & Palma. (2019) Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application. Cancers 11:7, pages 915.
Crossref
Li LiJun ZhangJuan ChenZijun Y. Xu-MonetteYi Miao, Min XiaoKen H. YoungSa WangL. Jeffrey MedeirosMichael Wang, Richard J. FordLan V. Pham. (2018) B-cell receptor–mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma. Blood 132:17, pages 1805-1817.
Crossref
Lan V. Pham, Shengjian Huang, Hui Zhang, Jun Zhang, Taylor Bell, Shouhao Zhou, Elizabeth Pogue, Zhiyong Ding, Laura Lam, Jason Westin, R. Eric Davis, Ken H. Young, L. Jeffrey Medeiros, Richard J. Ford, Krystle Nomie, Leo Zhang & Michael Wang. (2018) Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas. Clinical Cancer Research 24:16, pages 3967-3980.
Crossref
Lan V. Pham, Elizabeth Pogue & Richard J. Ford. (2018) The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas. Frontiers in Oncology 8.
Crossref
David ChironCéline BellangerAntonin PapinBenoit TessoulinChristelle DoussetSophie MaigaAnne Moreau, Julie EsbelinValérie Trichet, Selina Chen-Kiang, Philippe MoreauCyrille TouzeauSteven Le GouillMartine AmiotCatherine Pellat-Deceunynck. (2016) Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma. Blood 128:24, pages 2808-2818.
Crossref
Lan V. Pham, Gary Lu, Archito T. Tamayo, Juan Chen, Pramoda Challagundla, Jeffrey L. Jorgensen, L. Jeffrey Medeiros & Richard J. Ford. (2015) Establishment and characterization of a novel MYC/BCL2 “double-hit” diffuse large B cell lymphoma cell line, RC. Journal of Hematology & Oncology 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.